|
|
|
|
|
Trends In Prefilled Syringes
|
|
|
| By
Oskar Gold
|
|
|
|
An interview with Vetter's Oskar Gold about the trends and growth in prefilled syringes.
|
|
|
|
Prefilled Syringes: Challenges, Innovations And Market
|
|
|
| By
Raul Soikes
|
|
|
|
The pharma industry is constantly seeking drug delivery technologies that can increase compliance, improve the quality of delivered care, reduce medication errors and reduce the possibility of admixture-related contamination.
|
|
|
|
Needle-Free Injection
|
|
|
| By
Dr Charles Potter
|
|
|
|
Needle-free injection technologies have been developed for injecting liquid formulations, as well as injecting drugs and vaccines in a solid dosage form.
|
|
|
|
Why Syringes Continue To Dominate The Parenteral Drug Delivery Market
|
|
|
| By
William Dierick
|
|
|
|
The application of the first piston syringes to treat medical complications was described in Roman times during the 1st century, and forms of intravenous injection and infusion began as early as 1670.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trends Towards Standardisation
|
|
|
| By
Jerold Martin
|
|
|
|
Over the past 10 years or so, we've seen single-use technologies explode from production-scale filter capsules, tubing and simple biocontainers to encompass sterile connectors, membrane chromatography adsorbers, bioreactors, mixers, and integrated platform systems with increasing levels of sensors and automated controls.
|
|
|
|
|
|
|
|
|
Generics Dispute EU-India Trade Negotiations
|
|
|
| By
Nathan Jessop
|
|
|
|
The recent India–EU summit was expected to bring news about the upcoming Free Trade Agreement between the EU and India; however, a dispute regarding the supply of generic drugs from India to developing countries has taken centre stage.
|
|
|
|
|
|
|
|
|
News
|
|
|
|
GSK to pay more than $4 billion for criminal and legal charges; FDA gains food recall authority... are drugs next?
|
|
|
|
|
|
|
|
|
Trade show trade down?
|
|
|
| By
Fedra Pavlou
|
|
|
|
I can't remember a day go by in the last few years when I haven't received an email or item of mail inviting me to attend a conference or trade event
|
|
|
|